Logo for FT News podcast

The effort to develop an Ebola vaccine has made progress recently, but too late to save those who died during last year's epidemic. Scientists are now racing to find a vaccine against the Zika virus. Andrew Ward, FT pharmaceuticals correspondent, asks Charlie Weller of the Wellcome Trust why scientists are so often behind the curve. Music by David SappaRead more on vaccines in an FT Special Report at ft.com/vaccines

Be alerted on News podcast

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.